Myriad Genetics
MYGN
#6755
Rank
A$0.96 B
Marketcap
A$10.37
Share price
-1.57%
Change (1 day)
-53.25%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2025 (TTM): -A$0.65 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are A$0.82 Billion. In 2024 the company made an earning of -A$0.19 Billion, an increase over its 2023 earnings that were of -A$0.4 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.65 Billion253.15%
2024 -A$0.19 Billion-53.49%
2023 -A$0.4 Billion88.72%
2022 -A$0.21 Billion172.08%
2021 -A$76.1 Million
2019 -A$39.63 Million-175.14%
2018 A$52.73 M-70.81%
2017 A$0.18 B22.22%
2016 A$0.14 B-38.8%
2015 A$0.24 B-6.12%
2014 A$0.25 B-41.07%
2013 A$0.43 B46.67%
2012 A$0.29 B15.84%
2011 A$0.25 B17.6%
2010 A$0.21 B-15.96%
2009 A$0.26 B
2007 -A$62.8 Million40.96%
2006 -A$44.56 Million
2003 -A$51.74 Million34.8%
2002 -A$38.38 Million89.21%
2001 -A$20.29 Million3.93%
2000 -A$19.52 Million21.76%
1999 -A$16.03 Million-25.61%
1998 -A$21.55 Million38.83%
1997 -A$15.53 Million-24.26%
1996 -A$20.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Bio-Rad Laboratories
BIO
-A$1.27 Billion 101.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-A$1.47 Billion 131.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-A$52.69 Million-91.64%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$1.02 B-262.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$12.26 B-2,044.56%๐Ÿ‡บ๐Ÿ‡ธ USA